Skip to content

Photo with eleven men and women, with the label "TAG History"
1/4/6x24: A Campaign to Rally Energy, Political Will, and Funding to End TB
Report cover that reads" Pipeline Report 2023. Pipeline report is white text, and 2023 is gray. The main cover is black with a graphic of blue wavy lines

Pipeline Reports

The current ones are all online and available for download now.

April 18, 2024
TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing
Webinar / Presentation
On May 15, join Treatment Action Group for a webinar on the TB Diagnostics Pipeline: New Tools & Opportunities to Improve Access to Testing.

April 15, 2024
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

April 10, 2024
Treatment Action Group (TAG) seeks a highly motivated and organized Administrator to support the organization as it continues to grow. This position reports to TAG’s Director of Operations and Human Resources. This is a full-time, salaried position.

April 2, 2024
Treatment Action Group Is Organizational Sponsor of SYNChronicity 2024
Statement / Press
Treatment Action Group (TAG) is proud to be one of the organizational sponsors of SYNChronicity 2024 (SYNC 2024). This annual national conference for HIV, HCV, STIs, harm reduction, and LGBTQ health will be held in Arlington, Virginia, from May 29 – 31; more than 1500 attendees are expected to participate.

March 27, 2024
1/4/6×24 Mid-Campaign Report Launch Webinar
Webinar / Presentation
On March 27, 2024, the 1/4/6×24 Campaign and the Stop TB Partnership co-hosted a webinar to launch the Campaign’s new report: Getting Better Faster: Delivering on the Promise of New TB Treatments.

March 22, 2024
Mid-Campaign Report Highlights What’s Needed to Win Better, Shorter TB Treatments for All by End of 2024
Statement / Press
Universal implementation of the best available treatment for drug-susceptible tuberculosis (TB) stands to cut 6.3 million years off total treatment by 2030, a new analysis released today by the 1/4/6×24 Campaign coalition has found.

March 21, 2024
Getting Better Faster: Delivering on the Promise of New TB Treatments – A Report from the 1/4/6×24 Campaign
This report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of best available TB regimens — as little as one month or once weekly for TB prevention, four months for drug-susceptible TB, and six months for drug-resistant TB — by the end of 2024.

March 18, 2024
Research in Action Awards 2024
Save the Date: Thursday, October 17, 2024, when our Research in Action Awards return this fall! Once again we’ll honor some of the most brilliant activists, scientists, and leaders in the fight to end HIV, tuberculosis (TB), and hepatitis C (HCV).

March 14, 2024
Navigating Change: Implementing Long-Lasting Injectable PrEP Treatment and the Evolution of Clinical Protocols
Webinar / Presentation
On March 26, 2024, TAG presented this webinar that discusses implementing long-lasting injectable PrEP treatments and the evolving landscape of HIV prevention.

March 14, 2024
2024 CROI Tuberculosis Research Round Up
Statement / Press
Treatment Action Group (TAG) welcomes the tuberculosis (TB) data presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). The highlights presented here cover the results of several phase II TB prevention and treatment trials.

March 12, 2024
TB Project Associate
Treatment Action Group (TAG) is seeking a highly motivated and organized TB Project Associate to support TAG’s advocacy portfolio on tuberculosis (TB). This position will report to the TB Project Co-Director and be based in New York City.

March 11, 2024
Policy Issue Briefs: BARDA and ARPA-H
These two policy briefs explore two as yet untapped sources for drug-resistant tuberculosis (DR-TB) research funding within the U.S. Department of Health and Human Services (HHS).

March 2, 2024
2024 Pre-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2024 Pre-CROI Community HIV Cure Research Workshop took place on Saturday, March 2nd in Denver. This year’s workshop had a shorter format than in the past, but we plan to return to an all-day event in the future.

February 29, 2024
TPT Community Materials
These free educational materials are designed for community-based and civil society organizations to use to advocate for and teach people about TB preventive treatment (TPT).

February 28, 2024
Washington D.C. Community Consensus on the Earlier Inclusion of Pregnant Women and Persons in TB Research
In October 2023, sixteen members of the global TB community developed a consensus statement on the inclusion of pregnant and breastfeeding women and persons in TB treatment and vaccines research.

February 16, 2024
Effective Approaches to Engaging HIV Positive Homeless Populations
Webinar / Presentation
On February 27, 2024, TAG explored innovative strategies and successful interventions for addressing the unique challenges faced by people living with HIV who are experiencing homelessness.

February 14, 2024
TAG Announces New Board Leadership
Statement / Press
Treatment Action Group (TAG), the New-York-City-based activist research and policy think tank working to end the epidemics of HIV, TB, and hepatitis C, made leadership changes at its annual Board of Directors meeting on February 10, 2024.

February 7, 2024
TAG Statement on 2024 National Black HIV/AIDS Awareness Day (NBHAAD)
Statement / Press
In the collective effort to engage, educate, and empower advocates around the ongoing impacts on Black communities, and to raise awareness around persistent and new threats to equitably ending the HIV epidemic, this National Black HIV/AIDS Awareness Day beckons us to confront the shadows that linger within our communities, specifically among our Black and Brown queer community members.

January 30, 2024
Health Activist Groups: Defunding UNRWA in Gaza Is an Act of Depravity and Enables a Genocide
Statement / Press
We are appalled. As organisations that have historically worked on issues of health justice and access to medicines for millions of people around the world, for decades, focusing on HIV/AIDS, TB, cancer, and COVID, we share the urgent concern and outrage of aid organizations (NGOs) that the sudden decision by global north donor countries to suspend funding for the United Nations Relief and Works Agency (UNRWA) ‘’comes amid a rapidly worsening humanitarian catastrophe in Gaza.”

January 10, 2024
NOW Is the Time for Hepatitis C Virus Elimination
Hepatitis C-related liver diseases continue to kill an estimated 15,000 people per year in the United States, despite the availability of an effective cure.

December 21, 2023
Statement from TAG, Global TB CAB on H56:IC31 Phase IIb Trial Results
Statement / Press
This week, the Statens Serum Institut (SSI) and IAVI shared topline results of the phase IIb trial of H56:IC31, a subunit TB vaccine developed by SSI in Denmark consisting of four Mycobacterium tuberculosis antigens and the IC31 adjuvant made by Valneva.

December 19, 2023
In Memoriam — Nancy Brooks Brody
September 12, 1962 – December 8, 2023. Treatment Action Group mourns the loss of artist and activist Nancy Brooks Brody, who created the 2021 Limited Art Edition Book Marks for TAG. A native New Yorker, Brody was a member of the artist collective fierce pussy alongside Joy Episalla, Zoe Leonard, and Carrie Yamaoka, from 1991 to 2023. In 2010 fierce pussy created the TAG Limited Art Edition Twisted. We celebrate Brody’s fierce passion, brilliance, and commitment to solidarity and social justice, which lit up our world, through her art and life. TAG extends our condolences to her chosen family, friends, and fierce pussy colleagues.

December 13, 2023
Communities as Actors in the Research and Development Process
This publication explores the role of community engagement in health-related research and development (R&D), particularly within the Unitaid-funded LONGEVITY Project.

December 5, 2023
A Community Update on AbbVie’s HIV Cure Research Program
Webinar / Presentation
This webinar was held on December 5, 2023, and provided an update on HIV cure-related research studies being conducted by the company AbbVie; the recording of the webinar is now online.

December 5, 2023
Report: TB R&D Funding Perilously Off Track of UN Commitments to End Disease by 2030
Statement / Press
A new report released today by Treatment Action Group (TAG) and the Stop TB Partnership has found that cumulative funding for tuberculosis (TB) research and development (R&D) over the past five years is falling shockingly short of commitments.

Back To Top